Zenition 30 1
Zenition 30 1
Zenition 30 1
Zenition 30
Give your surgical teams simple, �exible imaging to make fast, informed decisions with
Philips Image Guided Therapy Mobile C-arm System 3000 – Zenition 30. Features such as
unique Surgeon Control, User Pro�les and the Touch Screen Module offer personalized
control and clarity to enhance speed and decision-making for users working with
constrained facilities.
Please turn over to learn the key �ndings about these features from the claims
substantiation studies performed with EU and USA-based clinicians.
Involving
In 2022, two claims substantiation studies were conducted for the
Zenition 30 system, in Best (Netherlands) and Cleveland (Ohio, USA).
16 clinicians
from the EU
In each case, the OR environment was simulated with clinical users
(including orthopedic surgeons, vascular surgeons, abdominal
surgeons, technologists, and OR nurses) in a test lab environment.
34 clinicians
from the USA
Key �ndings
84% of users 1
84% of users2
believe that the dedicated pediatric mode
believe the combination of Surgeon
could lead to more con�dence in treating
Control and the Touch Screen Module
pediatric patients
can reduce the need for supporting staff
97% of users 2
98% of users3
believe that the electromagnetic brakes
said that the Surgeon Control gave them
support an efficient work�ow
a strong feeling of control during C-arm
angulations
84% of users 3
90% of users4
who experienced the Touch Screen
believe that using personalized IQ
Module believe that being able to control
pro�le, fewer images might be
the radiation/image acquisition settings
needed during a procedure as the
could lead to lower radiation exposure
�rst image already incorporates the
preferred settings
Outstanding user Enhance your clinical Increase surgeon Reduce work�ow Allow surgeons to focus
experience capabilities autonomy and control steps more on surgery and
less on communication
1 Results obtained during claims substantiation study performed in February and Septem-
ber 2022 by Use-Lab GmbH, an independent company. Response is based on 42 clinicians
around the world, who answered a questionnaire subsequent to a usability study with
additional hands-on time with the system.
2 Results obtained during claims substantiation study performed in February and Septem-
ber 2022 by Use-Lab GmbH, an independent company. Response is based on 37 clinicians
around the world, who answered a questionnaire subsequent to a usability study with
additional hands-on time with the system.
3 Results obtained during claims substantiation study performed in February and Septem-
ber 2022 by Use-Lab GmbH, an independent company. Response is based on 50 clinicians
around the world, who answered a questionnaire subsequent to a usability study with
© 2023 Koninklijke Philips N.V. All rights reserved. additional hands-on time with the system.
4 Results obtained during claims substantiation study performed in February and Septem-
ber 2022 by Use-Lab GmbH, an independent company. Response is based on 41 clinicians
www.philips.com around the world, who answered a questionnaire subsequent to a usability study with
additional hands-on time with the system.
- Pending 510(k), Not available for sale in the U.S.A.
- Zenition 30 mobile C-arm systems are available for sale in a limited number of countries.
4522 991 82831 * JUL 2023 Please check with your local representative for availability in your market.